A recent report out of Oregon found “significant disparities in reimbursement” between retail pharmacies in the study and all other pharmacy providers, as reported to the Oregon Medicaid program.
This month, the Oregon State Pharmacy Association (OSPA), in conjunction with 3 Axis Advisors, released a new report called Understanding Pharmacy Reimbursement Trends in Oregon. The 155-page report describes how Oregon Pharmacy Benefit Managers (PBMs) have routinely abused their power as the middleman of the health insurance industry to over-inflate prescription drug prices at the expense of local pharmacies, taxpayers and patients.
Comentarios